Dementia

The Multimodal Imaging of Neurodegenerative Disease (MIND) Unit uses multimodal neuroimaging, high-throughput proteomic, and genetic approaches to understand how peripheral immune function, infection, and neuroinflammation influence the development and progression of the brain changes underlying Alzheimer's disease and related dementias. In addition to our investigative efforts, the MIND Unit is committed to achieving several key objectives.

Although rapid strides have been made in understanding the basic biology of Alzheimer's disease (AD), this knowledge has not been translated into earlier diagnosis and/or effective treatments for patients. The overarching goal of research in the Clinical and Translational Neuroscience Section (CTNS) is to comprehensively study the biologic basis of AD pathogenesis in humans.